Dr. Hockenbery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000Fax+1 206-598-6963
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 1986 - 1992
Johns Hopkins UniversityResidency, Internal Medicine, 1982 - 1985- Washington University in St. Louis School of MedicineClass of 1982
Certifications & Licensure
WA State Medical License 1992 - 2025
MD State Medical License 1985 - 1986- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2002
Clinical Trials
- Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Start of enrollment: 2000 Jul 01
- Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD) Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- 3088 citationsBcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathDavid M. Hockenbery, Gabriel Núñez, Curt L. Milliman, Robert D. Schreiber, Stanley J. Korsmeyer
Nature. 1990-11-22 - 2845 citationsBcl-2 functions in an antioxidant pathway to prevent apoptosisDavid M. Hockenbery, Zoltán N. Oltvai, Xiao Ming Yin, Curt L. Milliman, Stanley J. Korsmeyer
Cell. 1993-10-22 - 178 citationsInduction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cellsTracie Delgado, Patrick A. Carroll, Almira S. Punjabi, Daciana Margineantu, David M. Hockenbery
Proceedings of the National Academy of Sciences of the United States of America. 2010-06-08
Journal Articles
- Pan-Cancer Transcriptional Signatures Predictive of Oncogenic Mutations Reveal That Fbw7 Regulates Cancer Cell Oxidative MetabolismDavid M Hockenbery, Bruce E Clurman, Proceedings of the National Academy of Sciences
Press Mentions
Dr. David M. Hockenbery, Recipient of the 2022 Dr. Ali Al-Johani AwardMarch 15th, 2022- Can a Tumor That Acts like a Microbe Help Us Develop Better Cancer Therapies?August 6th, 2020
How a Phone Call Helped Shape the Field of Bone Marrow TransplantJanuary 30th, 2019
Grant Support
- Metabolism, Protein And Mirna Cross-Talk In Cell Cycle And Tumor ProgressionNational Cancer Institute2012
- Biomarker Discovery For Mitochondrial Toxicants Using Metabolic FootprintingNational Institute Of Environmental Health Sciences2011
- Metabolic Alterations In Advanced Breast Cancer And Response To Systemic Therapy.National Cancer Institute2010–2011
- Mechanisms Linking Nutrient Supply &Cell Cycle/SurvivalNational Cancer Institute2008–2009
- Cell Metabolism And MYC Induced Growth, Death, And NeoplasiaNational Cancer Institute2007–2009
- Regulation Of Substrate-Linked Mitochondrial ROS GenerationNational Cancer Institute2006–2007
- Cell Metabolism &Myc Induced Growth Death, &NeoplasiaNational Cancer Institute2006
- Cell Metabolism &Myc Induced Growth, Death, &NeoplasiaNational Cancer Institute2005
- Small Molecule Inhibitors Of BCI XL Survival ProteinNational Cancer Institute2001–2004
- Mitochondrial Control Of Intestinal ApoptosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
- Role Of BCL 2 Related Genes In HematopoiesisNational Heart, Lung, And Blood Institute1997–1999
- Apoptotic Pathways In B Lymphocyte ActivationNational Institute Of General Medical Sciences1997
- Apoptosis And The Epidemiology Of Breast CancerNational Cancer Institute1995–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
